tirzepatide and mash in Metabolically Dysfunctional‐Associated Steatohepatitis (MASH): A Bibliometric Evidence‐Based Review - Pantea - 2026 - Journal of Diabetes Research tirzepatide #mash | Scott Isaacs,

Since that time, GP-1s have gained FDA approval for the treatment of cardiovascular disease, obesity, sleep apnea and kidney disease

GLP-1s are primarily used to treat diabetes and obesity by mimicking hormones to regulate blood sugar and reduce appetite

As new treatment modalities emerge, clinicians must be equipped to navigate patient conversations about options, expectations, and adherence strategies

The episode highlights the growing influence of social media in shaping political conversations, where even subtle visual differences can trigger widespread debate, speculation, and division, often blurring the line between reality and interpretation in the middle of an intense election season

Glutathione is not the enemy

3.4 Quality of life outcomes Four studies reported the SF-36v2, and 3 reported the IWQOL-Lite-CT